Lycia Therapeutics, Inc. (LYCA)
NASDAQ: LYCA · Real-Time Price · USD
26.40
-1.33 (-4.80%)
Oct 30, 2026, 4:00 PM EST - Market closed
Lycia Therapeutics Market Cap
Lycia Therapeutics has a market cap or net worth of $1.52 billion as of October 30, 2026. It is the 7,758th most valuable company in the world and the 1,964th biggest in the United States.
Market Cap
1.52B
Enterprise Value
1.38B
1-Year Change
n/a
Global Rank
Country Rank
#1,964 United States
Category
ChartMarket Cap Chart
Since the IPO on October 23, 2026, Lycia Therapeutics's market cap has increased from $937.70M to $1.52B, an increase of 62.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.52B | -4.80% |
| Oct 29, 2026 | 1.60B | 10.70% |
| Oct 28, 2026 | 1.44B | -4.06% |
| Oct 27, 2026 | 1.51B | -9.50% |
| Oct 26, 2026 | 1.66B | 77.46% |
| Oct 23, 2026 | 937.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mineralys Therapeutics | 1.61B |
| UroGen Pharma | 1.60B |
| Nanobiotix | 1.60B |
| Ultragenyx Pharmaceutical | 1.58B |
| Immunocore Holdings | 1.57B |
| Structure Therapeutics | 1.56B |
| Innoviva | 1.53B |
| Ocular Therapeutix | 1.53B |